Local Institution

Moncton, New Brunswick E1G 1A7

0 studies enrolling now · 11 studies all time

What they study most

Advanced Cutaneous Melanoma, Bladder Cancer, Diabetes Mellitus, Type 2, Melanoma, Metastasis, Non-Small-Cell Lung Carcinoma, Prostatic Neoplasms, Stage III (Unresectable) or Stage IV Advanced Melanoma, Transitional Cell Carcinoma, Type 2 Diabetes

Studies at this site

• A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma — Completed
• Add-on to Thiazolidinedione (TZD) Failures — Completed
• A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus — Completed
• Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer — Completed
• Expanded Access Program With Nivolumab to Treat Melanoma — NO_LONGER_AVAILABLE
• A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies — Completed
• Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes — Completed
• First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy — Completed
• Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer — Completed
• A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise — Completed
• Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed